EU Health Ministers Discuss Proposal to Restrict Nicotine Product Flavors

Regulations by 2FIRSTS.ai
Jun.21.2024
EU Health Ministers Discuss Proposal to Restrict Nicotine Product Flavors
EU health ministers discuss proposals to restrict e-cigarette and nicotine product flavors, potentially affecting millions of consumers.

According to a report by Vaping360 on June 21st, today (the 21st), health ministers from all 27 European Union (EU) member states discussed proposals to restrict e-cigarette and other nicotine product flavors (including nicotine pouches). Their stance could lead to stricter regulations on e-cigarettes for millions of nicotine consumers in Europe.

 

The Employment, Social Policy, Health, and Consumer Affairs Committee (EPSCO), one of the 10 "agencies" of the European Commission, will consider proposals from Latvia and Denmark to support a ban on flavorings and crack down on cross-border sales within the EU.

 

Latvia's proposal also received support from delegations from Cyprus, Estonia, Ireland, Lithuania, Luxembourg, Malta, Portugal, Slovenia, and Spain. Denmark's suggestion was endorsed by Estonia, Finland, France, Germany, Ireland, Luxembourg, Malta, the Netherlands, Poland, Slovenia, and Spain.

 

If the health ministers reach a consensus on these proposals, the next step will be to ask the European Commission to draft legislation, which will ultimately be voted on by the Council and the European Parliament. During this process, elections in various countries may soften or strengthen support for bans on certain flavors.

 

Currently, seven countries in the European Union have passed laws banning e-cigarette flavors: Denmark, Estonia, Finland, Hungary, Lithuania, the Netherlands, and Slovenia. Spain recently completed a public consultation on a proposal to ban flavors, while Latvia is introducing flavor restrictions. Currently, no European country has passed a total ban on e-cigarettes.

 

The existing Tobacco Products Directive (TPD) regulates nicotine and tobacco product standards within the European Union, allowing each member state to establish its own flavor regulations.

 

However, according to Latvia's recommendations, individual bans are ineffective because "there is no complete ban on cross-border remote sales of tobacco or related products (including e-cigarettes) at the EU level, and cross-border sales are not prohibited.

 

Due to continued discrepancies among member states in the regulation of flavors and additives in e-cigarette liquids, as well as cross-border distance sales, it is necessary to establish further common regulations at the EU level.

 

Denmark's proposal calls for stricter requirements and urges the European Union to allow member states to ban specific categories of nicotine products.

 

These initiatives should include a ban on flavored nicotine products, restrictions on nicotine content in these products, and the ability to prohibit certain products when necessary. More broadly, we call on the European Commission to initiate a debate on nicotine products and allow for a review of various possible regulations that would enable member states to potentially ban defined product categories.

 

The European Tobacco Harm Reduction Advocates (ETHRA) has written a letter to all EU health ministers, opposing the proposed flavor ban and explaining its consequences. "We hope to proceed cautiously in the discussion and provide some factual background. The proposed measures are unlikely to protect young people and may have more disadvantages than benefits. A total or partial ban on the production and supply of new nicotine products will not eliminate the basic demand for nicotine. All safer nicotine products have some form of flavor (including tobacco flavor), so a flavor ban is effectively a substantial ban on the products.

 

Prohibition will not make the banned products disappear or diminish demand.

 

ETHRA has provided four strategies to reduce teenagers' exposure to e-cigarettes and other nicotine products:

  • Legal regulated market; 
  • Age verification retail system; 
  • Marketing control; 
  • Taste description control. 

 

The organization is calling on EU health ministers to base the upcoming revision of the major EU Tobacco Products Directive on "evidence, careful consideration, and meaningful consultation.

 

These directives could have life-threatening or life-saving implications for European citizens, and we should not begin revising based on preconceived outcomes that rely on weak or misleading evidence.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Altria’s USSTC Starts $250 Million Kentucky Expansion, Adding More Than 200 Jobs
Altria’s USSTC Starts $250 Million Kentucky Expansion, Adding More Than 200 Jobs
U.S. Smokeless Tobacco Company, an Altria Group company, has broken ground on an approximately $250 million manufacturing expansion in Hopkinsville, Kentucky. The roughly 270,000-square-foot facility is expected to create more than 200 jobs and absorb processing, manufacturing and packaging operations currently split between Hopkinsville and Nashville, Tennessee. USSTC previously said production at its Nashville facility is expected to wind down by early 2028. The project forms part of Altria’s broader effort to modernize and consolidate its U.S. smokeless tobacco manufacturing network.
Sep.10
Snowplus Enters Japan’s FamilyMart Network With Zero-Nicotine NEO Line and Kishidan Campaign
Snowplus Enters Japan’s FamilyMart Network With Zero-Nicotine NEO Line and Kishidan Campaign
Snowplus distributor H&S said the zero-nicotine, zero-tar NEO vaping line will begin rolling out across FamilyMart stores in Japan from September 14, 2026, excluding some locations. The DASH line will also be sold at selected FamilyMart stores in southern Kyushu and Okinawa. Snowplus simultaneously named Japanese rock band Kishidan as a brand ambassador, combining convenience-store distribution with a broader consumer marketing push in Japan.
Sep.15
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Germany Probes 7.6 Million Illegal Vape Case With Estimated €33.3 Million Tax Loss; Four Chinese Manufacturer Employees Under Investigation, Some Packaging in Enforcement Images Resembles FUMOT Products
Germany Probes 7.6 Million Illegal Vape Case With Estimated €33.3 Million Tax Loss; Four Chinese Manufacturer Employees Under Investigation, Some Packaging in Enforcement Images Resembles FUMOT Products
German prosecutors and customs authorities are conducting a criminal investigation into an alleged cross-border organised vape network. Authorities say that between January 2024 and March 2025, four employees of an unnamed Chinese e-cigarette manufacturer allegedly built a network of sales agents and wholesalers that brought more than 7.6 million nicotine disposable vapes into Germany, causing an estimated €33.3 million in excise-tax losses. The manufacturer has not been named. Some products visible in enforcement images have packaging resembling products from FUMOT’s portfolio. European regulatory records from 2024, FUMOT’s public overseas-sales materials and records involving German vape importer and distribution company Zamu-Pro GmbH also show FUMOT/RandM products and German distribution activity during the period covered by the investigation.
Sep.21
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
Ahead of the Formula 1 race in Madrid, 67 Spanish and international public-health, medical and consumer organizations have sent an open letter to F1 President and CEO Stefano Domenicali calling for an end to sponsorships linked to the tobacco and nicotine industry, including nicotine pouches, vaping products and heated tobacco. The letter focuses on Philip Morris International’s ZYN partnership with Ferrari and British American Tobacco’s long-running partnership with McLaren and exposure for VELO. The campaign follows a March letter in which more than 160 organizations worldwide made a similar request to Formula 1.
Sep.10
Pennsylvania Vape Directory Law Survives Court Challenge From Nova Distro and Others Amid Similar Rulings Across States
Pennsylvania Vape Directory Law Survives Court Challenge From Nova Distro and Others Amid Similar Rulings Across States
A U.S. federal court upheld Pennsylvania's vape directory law on October 14, rejecting a challenge brought by Nova Distro, 101 Distributors and companies operating Tobacco Hut retail stores. Court records show that vaping accounts for about 60% of Tobacco Hut's profits and that the chain held approximately $2 million in inventory potentially subject to seizure under the law as of June 2. Pennsylvania began enforcement on October 19. The ruling follows similar appellate decisions in other states, even as new research shows that unlisted vaping products continue to account for substantial sales in states with established directories.
Regulations
Oct.22